This company seems to have been delisted
Reason: Acquired by Biosynex
Last recorded trade on: June 30, 2023
Source: https://www.globenewswire.com/en/news-release/2023/04/27/2656944/21088/en/Biosynex-Completes-Acquisition-of-Chembio-Diagnostics-Inc.html
Reason: Acquired by Biosynex
Last recorded trade on: June 30, 2023
Source: https://www.globenewswire.com/en/news-release/2023/04/27/2656944/21088/en/Biosynex-Completes-Acquisition-of-Chembio-Diagnostics-Inc.html
Chembio Diagnostics
CEMI
₹38.89
Share price
0.22%
Change (1 day)
-55.14%
Change (1 year)
Categories
Chembio Diagnostics (CEMI) - Total liabilities
Total liabilities on the balance sheet as of December 2022 : ₹3.83 Billion
According to Chembio Diagnostics's latest financial reports the company's total liabilities are ₹3.83 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Chembio Diagnostics - Total liabilities on balance sheet (from 2001 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | ₹3.70 B | 27.79% |
| 2021-12-31 | ₹2.90 B | 6.91% |
| 2020-12-31 | ₹2.71 B | 20.1% |
| 2019-12-31 | ₹2.26 B | 361.33% |
| 2018-12-31 | ₹0.48 B | 116.94% |
| 2017-12-31 | ₹0.22 B | -2.42% |
| 2016-12-31 | ₹0.23 B | 10.39% |
| 2015-12-31 | ₹0.20 B | -37.42% |
| 2014-12-31 | ₹0.33 B | 25.83% |
| 2013-12-31 | ₹0.26 B | 40.51% |
| 2012-12-31 | ₹0.18 B | 19.75% |
| 2011-12-31 | ₹0.15 B | 7.75% |
| 2010-12-31 | ₹0.14 B | -1.93% |
| 2009-12-31 | ₹0.14 B | -6.65% |
| 2008-12-31 | ₹0.16 B | 76.03% |
| 2007-12-31 | ₹91.13 M | -76.74% |
| 2006-12-31 | ₹0.39 B | 343.39% |
| 2005-12-31 | ₹88.36 M | -53.39% |
| 2004-12-31 | ₹0.18 B | |
| 2003-09-30 | ₹0.06 M | -98.7% |
| 2002-09-30 | ₹5.33 M | 80.7% |
| 2001-09-30 | ₹2.95 M | |
| 2001-03-31 | ₹0.37 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | ₹293.98 B | 7,574.34% | 🇺🇸 USA |
 | ₹238.90 B | 6,136.58% | 🇺🇸 USA |
 | ₹10.58 B | 176.23% | 🇮🇪 Ireland |
 | ₹5.92 B | 54.69% | 🇺🇸 USA |